biospecimen__admin__batch_number	231.65.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	74F52902-87CD-448A-927A-E788B7D6FA9A
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A3A6-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A3A6-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A3A6-01A
biospecimen__bio__biospecimen_barcode_bottom	0118957361
biospecimen__bio__day_of_creation	04
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	10
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-DD-A3A6.EEA9EFFB-B5F9-42D9-B452-E165E018C33C.pdf
biospecimen__bio__plate_column	7
biospecimen__bio__plate_id	A22J
biospecimen__bio__plate_row	G
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2012
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A3A6
biospecimen__shared__patient_id	A3A6
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	63C434DD-2694-42E4-8D80-5BA4F3B0D6F9
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.3
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.4
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	0.9
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.0
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.4
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	12.0
clinical__chol_lihc_shared__platelet_result_lower_limit	0
clinical__chol_lihc_shared__platelet_result_upper_limit	6
clinical__chol_lihc_shared__prothrombin_time_result_value	9.3
clinical__chol_lihc_shared__specimen_collection_method_name	Extended Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.1
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	72
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A3A6-F42703
clinical__clin_shared__bcr_followup_uuid	791E8328-55D8-4487-9C71-8D3B2A7C5173
clinical__clin_shared__day_of_form_completion	27
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	4
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	4
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	1997
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	4th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	b223fb81-3df8-40ad-a125-c8ec6d471cbc
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A3A6-01A-11R-A22J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	4057486f-2f4e-4f8e-89ed-e778a43fb755
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.78
gdc__analytes__analyte_id	f59ae78f-8207-44b5-9fb1-0ddcfa6b7d77
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	c4c4820b-6f4c-4cdd-b233-4d22f5933fd9
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:49:30.029218-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	3d91cd54-9f1b-5418-ae1c-f1f73cb550c4
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1925
gdc__demographic__year_of_death	2005
gdc__diagnoses__age_at_diagnosis	26319
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-26319.0
gdc__diagnoses__days_to_death	3258.0
gdc__diagnoses__diagnosis_id	706e9fae-f413-519c-aaaf-5e93ce23a24c
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	16.979591836734695
gdc__exposures__exposure_id	a083b8d5-19d0-5984-aa04-508be690a433
gdc__exposures__height	175.0
gdc__exposures__weight	52.0
gdc__file_id	68143333-f540-4a02-9cbd-e4783c25175b
gdc__file_name	8f1b5875-074e-4000-b83f-733d45b9801e.mirbase21.mirnas.quantification.txt
gdc__file_size	50337
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	26a8c95100bdd0dc5c814c78faaeee32
gdc__portions__is_ffpe	false
gdc__portions__portion_id	9a61190e-9c23-4316-9d78-d48ec7bb984a
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	5304
gdc__samples__initial_weight	150.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	EEA9EFFB-B5F9-42D9-B452-E165E018C33C
gdc__samples__sample_id	8bbfeeab-ff99-4bd0-b407-e1e532bd04fc
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	97.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	617435de-4b82-4206-ac4f-9695f3ece9e4
gdc__submitter_id	mirna_swap_dr11_376_MirnaExpressionaa0a925d-cfc6-4506-9915-774d3680a526_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	fc18cfe5-ba14-52a8-a8d8-2fb296c85365
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:10:37.818+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/b223fb81-3df8-40ad-a125-c8ec6d471cbc-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/b223fb81-3df8-40ad-a125-c8ec6d471cbc-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129708
manually_curated__local_md5	8234f45e736a8a3ba845ddc8f7011123
manually_curated__opengdc_download_date	2018-10-16T17:11:19.000525+02:00
manually_curated__opengdc_file_md5	25db8afcb7c8ecf008222df49dc9b570
manually_curated__opengdc_file_size	50336
manually_curated__opengdc_id	b223fb81-3df8-40ad-a125-c8ec6d471cbc-meq
manually_curated__origin_file_size	129708
manually_curated__origin_last_modified_date	Tue Oct 16 17:49:00 CEST 2018
manually_curated__origin_md5	8234f45e736a8a3ba845ddc8f7011123
manually_curated__tissue_status	tumoral
